AzTrials
AzTrials

Fecal IncontinenceNCT00307476

Comparison of Rectal Trumpet and Standard Care

A study testing Rusch Nasopharyngeal Airway in people with Fecal Incontinence, run by Christiana Care Health Services at 2 sites in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Primary: To determine the effectiveness of the rectal trumpet compared to the standard care in maintaining skin integrity in patients with fecal incontinence. Hypothesis (H1): There will be no difference in the failure rates of rectal area skin integrity between subjects receiving the rectal trumpet and those… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Fecal Incontinence
What is being tested?
Rusch Nasopharyngeal Airway
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
2 sitesUnited States
Study dates
1 Sep 2005to 25 Jun 2007
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diarrhea - two episodes of loose or watery stool in a 12 hour period
  • ≥ 18 years of age
  • English-speaking patient or guardian
  • Intact skin, may be reddened without breakdown
  • Doctor's order for rectal trumpet if patient randomized to treatment group

Who cannot join

  • prolapsed anal sphincter
  • active rectal bleeding
  • colorectal cancer
  • bleeding precautions
  • rectal tone rated 1 (gaping) or 2 (lax)

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Christiana Care Health Systems

    Newark, Delaware, 19718

  • Christiana Care Health Systems-Wilmington

    Wilmington, Delaware, 19801

Other trials in United States

About this study

Official title: A Clinical Comparison of the Rectal Trumpet and Standard Care in Acutely Ill Patients With Fecal Incontinence

Primary: To determine the effectiveness of the rectal trumpet compared to the standard care in maintaining skin integrity in patients with fecal incontinence.

Hypothesis (H1): There will be no difference in the failure rates of rectal area skin integrity between subjects receiving the rectal trumpet and those receiving treatment as usual (staqndard care).

Secondary: To determine the ease of use, cost-effectiveness, and level of patient comfort with the rectal trumpet compared to the standard care in patients with fecal incontinence.

Secondary (exploratory) hypotheses:

There will be differences in the ease of use of the devices, costs of the devices, and patient comfort relative to the devices.

Read the detailed description

Method:

Subjects:

A convenience sample of 80 adult male and female patients in the Wilmington Intensive Care Unit (WICU), Surgical Critical Care Center (SCCC), Medical Intensive Care Unit (MICU), and 6D Step-Down, TSU, 5A, 5E/W, will be recruited. After obtaining informed consent, subjects will be randomized to one of two groups (experimental: rectal trumpet or standard treatment: Hollister fecal incontinent collector).

Inclusion Criteria: Patients who meet the following criteria:

  1. Diarrhea - two episodes of loose or watery stool in a 12 hour period
  2. ≥ 18 years of age
  3. English-speaking patient or guardian
  4. Intact skin, may be discolored without breakdown
  5. Doctor's order for rectal trumpet (if randomized to treatment group)

Exclusion Criteria: Patients will be excluded from this study if any of the following are present:

  1. prolapsed anal sphincter
  2. active rectal bleeding
  3. colorectal cancer
  4. bleeding precautions
  5. rectal tone rated 1 (gaping) or 2 (lax)

Instruments:

The data collection instruments used in this study are investigator-developed (see Appendix A - Data Collection Tool). Data will be collected by study and unit nurses at baseline, every eight hours, and PRN throughout the duration of the study. Data will have subject identification removed and subject number assigned.

Digital pictures of patients with any identifying marks (e.g., tattoos, birthmarks, piercings) will have these marks edited out.

Procedure:

A comparison study will be conducted. The staff nurse will identify patients with two or greater episodes of loose or watery stool in a 12 hour period and contact study team. Study team member will determine if patient meets additional inclusion criteria #2, #3, #4, and #5 and does not have exclusion criteria #1, #2 or #3. Once this is determined, the study team member will approach patient or family for consent to participate in study. After consent is obtained, study team member will evaluate patient for remaining exclusion criteria (#4). Rectal tone will be assessed and rated by performing a digital rectal exam. If assessed tone is rated gaping (1) or lax (2), patient is excluded from study.

Patients meeting all study criteria will be randomized to either the rectal trumpet group or the standard treatment. The Numeric Pain Intensity Scale (0-10) or staff observation of physiological indicators (e.g., restlessness, sweating, tachycardia, lacrimation, pupil dilatation, poor ventilator synchrony) for disoriented or unresponsive patients will be used prior to and immediately after placement of either device in order to assess patient comfort. Comfort will be assessed every 8 hours on all oriented patients using the Numeric Pain Intensity Scale.

For placement of rectal trumpet (Rusch nasopharyngeal airway-32FR): Patient's skin is cleansed with Smith and Nephew Personal cleanser and rinsed thoroughly with water to remove any soap residue and dried. Apply 3M no sting barrier film to provide skin protectant. Attach the shaft end of the trumpet to a urinary drainage bag. Using hemostats, clamp the tubing beneath the sample port of the drainage bag. Instill 5cc of mineral oil through the flange end of the trumpet, being careful not to over fill or spill mineral oil onto flange. Release the clamp and allow the mineral oil to drain into urinary drainage bag. If possible, place patient into side-lying position with knees drawn toward the chest. Fold flange into quarters, insert into the rectum. Pull back gently until there is slight resistance. Secure the drainage bag to the bed frame. Drainage tubing should be positioned to prevent tension or pull on trumpet.

Staff will be educated on proper placement of both devices and need for reapplication/reinsertion of either device prior to study initiation. Education will be provided to staff on the following units: SCCC, MICU, 6DSD, and WICU.

Study patients will be assessed every 8 hours and PRN for signs of skin breakdown, stool leakage around devices, dislodgement, or discomfort from devices using the Numeric Pain Intensity Scale for oriented patients. Failure of the fecal incontinent collector will include: leakage within 24 hours of application X 2 attempts at placement, or skin breakdown. Failure of the rectal trumpet will include: leakage X 2 around trumpet with proper positioning within a 24 hour period, skin breakdown, expelling trumpet with continuation of diarrhea X 3 in a 24 hour period, or if the oriented patient, when assessed for discomfort every 8 hours, rates discomfort 2 points above previous rating level of discomfort or requests removal of device due to discomfort.

Selected digital pictures of patients' skin will be taken to establish inter-rater reliability with respect to skin assessment and to provide photographic evidence of skin maintenance, healing, or failure with use of either device. A representative from the Medical Photography department will instruct investigators on digital photographing of patients' skin. Completion of trial will be the return of continence, stool becoming formed, discharge from unit of study, or 14 days whichever comes first.

Being tested
Rusch Nasopharyngeal Airway
Keywords
Fecal Incontinence, Fecal Containment Devices, Skin Integrity
Medical subject headings
Fecal Incontinence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rusch Nasopharyngeal AirwayDevice

    For placement of rectal trumpet (Rusch nasopharyngeal airway-32FR): Patient's skin is cleansed with Smith and Nephew Personal cleanser and rinsed thoroughly with water to remove any soap residue and dried. Apply 3M no sting barrier film to provide skin protectant. Attach the shaft end of the trumpet to a urinary drainage bag. Using hemostats, clamp the tubing beneath the sample port of the drainage bag. Instill 5cc of mineral oil through the flange end of the trumpet, being careful not to over fill or spill mineral oil onto flange. Release the clamp and allow the mineral oil to drain into urinary drainage bag. If possible, place patient into side-lying position with knees drawn toward the chest. Fold flange into quarters, insert into the rectum. Pull back gently until there is slight resistance. Secure the drainage bag to the bed frame. Drainage tubing should be positioned to prevent tension or pull on trumpet.

Study groups in NCT00307476
Study groupRoleWhat they receive
rectal trumpetActive comparatorPatients meeting all study criteria will be randomized to either the rectal trumpet group or the standard treatment. For placement of rectal trumpet (Rusch nasopharyngeal airway-32FR):
Receives: Device: Rusch Nasopharyngeal Airway
standard treatmentOtherPatients meeting all study criteria will be randomized to either the rectal trumpet group or the standard treatment. The Numeric Pain Intensity Scale (0-10) or staff observation of physiological indicators (e.g., restlessness, sweating, tachycardia, lacrimation, pupil dilatation, poor ventilator synchrony) for disoriented or unresponsive patients will be used prior to and immediately after placement of either device in order to assess patient comfort. Comfort will be assessed every 8 hours on all oriented patients using the Numeric Pain Intensity Scale.
Receives: Device: Rusch Nasopharyngeal Airway

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Skin integrity

Secondary outcomes (3)
  1. Ease of use

  2. Cost effectiveness

  3. Patient comfort

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2006 (estimated)
  2. Study start1 Sep 2005
  3. Primary completion25 Jun 2007
  4. Study completion25 Jun 2007

Why it stopped: Unable to recruit target enrollment numbers

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00307476
Sponsor's protocol ID
24200
Status last verified
Feb 2023
First submitted
24 Mar 2006
Last updated
13 Feb 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: inadequate data to share

Questions about this trial

What is this clinical trial studying?

A study testing Rusch Nasopharyngeal Airway in people with Fecal Incontinence, run by Christiana Care Health Services at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 13 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Skin integrity. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in